NUR 670 Exam 2 with verified answers ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
Terms in this set (95) ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
Original
1. How are neurotransmitters removed from the synapse?
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- re-uptake into post-synaptic receptors.
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- re-uptake by surrounding beta cells.
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- re-uptake by surrounding alpha cells
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- axon degradation
||\\|//|| ||\\|//||
re-uptake into post-synaptic receptors. ||\\|//|| ||\\|//|| ||\\|//||
2. Which of the following statements about bioavailability is true?
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Bioavailability issues are especially important for drugs with narrow therapeutic ranges or
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
sustained-release mechanisms.
||\\|//|| ||\\|//||
- Drugs that are administered orally twice a day have greater bioavailability than IV drugs
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
given daily. ||\\|//||
- All brands of a drug have the same bioavailability.
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Combining an active drug with an inert substance does not affect bioavailability
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Bioavailability issues are especially important for drugs with narrow therapeutic ranges or
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
sustained-release mechanisms.
||\\|//|| ||\\|//||
,3. Which of the following is the most likely site of absorption of a controlled-release form
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
of an oral drug?
||\\|//|| ||\\|//|| ||\\|//||
- large intestines
||\\|//|| ||\\|//||
- liver
||\\|//||
- kidneys
||\\|//||
- lymphatic system
||\\|//|| ||\\|//||
large intestines ||\\|//||
4. _________is considered a Schedule I drug.
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Ketamine
||\\|//||
- amphetamines
||\\|//||
- alcohol
||\\|//||
- cannabis
||\\|//||
- cannabis
||\\|//||
5. Four major ethical principles are:
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Integrity, beneficence, non-malfeasance and trust
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Autonomy, beneficence, non-malfeasance and justice
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Duty, beneficence, malfeasance and justice
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Autonomy, beneficence, universality and justice
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Autonomy, beneficence, non-malfeasance and justice
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
6. The amount of drug available in the bloodstream is considered the:
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
,- Bioavailability of the drug
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Properties of protein-binding
||\\|//|| ||\\|//|| ||\\|//||
- Liver enzyme activity
||\\|//|| ||\\|//|| ||\\|//||
- First pass mechanism
||\\|//|| ||\\|//|| ||\\|//||
Bioavailability of the drug ||\\|//|| ||\\|//|| ||\\|//||
7. A patient is being treated with psychotropic medications. He wonders which of the
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
following would affect his medications, by acting as an enzyme inducer: ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Smoking
||\\|//||
- coffee with sugar
||\\|//|| ||\\|//|| ||\\|//||
- black coffee
||\\|//|| ||\\|//||
- grapefruit juice
||\\|//|| ||\\|//||
- Smoking
||\\|//||
8. A 22 y/o patient is newly diagnosed with bipolar I disorder. When asked if she will need
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
medications for the rest of her life, the PMHNP said, "Bipolar is a chronic disease which ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
generally requires medication to treat it." Which ethical principle was used?
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- fidelity
||\\|//||
- veracity
||\\|//||
- autonomy
||\\|//||
- maleficence
||\\|//||
- veracity
||\\|//||
9. Poor health outcomes among African Americans and other minorities are attributed to:
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
, - The genetic predisposition for illness found among minorities
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Poor adherence on the part of the African American patient
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Discrimination, cultural barriers, and lack of access to health care
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- The belief among African Americans that prayer is more powerful than drugs
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Discrimination, cultural barriers, and lack of access to health care
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
10. Non-adherence is especially common in drugs that treat psychiatric conditions, such as
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
depression. One way to reduce the likelihood of non-adherence to th drugs is to prescribe a ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
drug that:
||\\|//|| ||\\|//||
- Must be taken three times a day
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Requires several dosage titrations so that missed doses can be replaced with lower doses
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
to keep costs down ||\\|//|| ||\\|//|| ||\\|//||
- Has a tolerability profile with fewer of the adverse effects that are considered "irritating,"
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
such as nausea and dizziness ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Has a short half-life so that missing one dose has limited effect
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Has a tolerability profile with fewer of the adverse effects that are considered "irritating,"
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
such as nausea and dizziness ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
11. All Florida prescribers are required to register for:
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
DEA databank ||\\|//||
EFORCSE
F-FORCE
K-FORCE
EFORCSE
Terms in this set (95) ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
Original
1. How are neurotransmitters removed from the synapse?
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- re-uptake into post-synaptic receptors.
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- re-uptake by surrounding beta cells.
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- re-uptake by surrounding alpha cells
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- axon degradation
||\\|//|| ||\\|//||
re-uptake into post-synaptic receptors. ||\\|//|| ||\\|//|| ||\\|//||
2. Which of the following statements about bioavailability is true?
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Bioavailability issues are especially important for drugs with narrow therapeutic ranges or
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
sustained-release mechanisms.
||\\|//|| ||\\|//||
- Drugs that are administered orally twice a day have greater bioavailability than IV drugs
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
given daily. ||\\|//||
- All brands of a drug have the same bioavailability.
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Combining an active drug with an inert substance does not affect bioavailability
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Bioavailability issues are especially important for drugs with narrow therapeutic ranges or
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
sustained-release mechanisms.
||\\|//|| ||\\|//||
,3. Which of the following is the most likely site of absorption of a controlled-release form
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
of an oral drug?
||\\|//|| ||\\|//|| ||\\|//||
- large intestines
||\\|//|| ||\\|//||
- liver
||\\|//||
- kidneys
||\\|//||
- lymphatic system
||\\|//|| ||\\|//||
large intestines ||\\|//||
4. _________is considered a Schedule I drug.
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Ketamine
||\\|//||
- amphetamines
||\\|//||
- alcohol
||\\|//||
- cannabis
||\\|//||
- cannabis
||\\|//||
5. Four major ethical principles are:
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Integrity, beneficence, non-malfeasance and trust
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Autonomy, beneficence, non-malfeasance and justice
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Duty, beneficence, malfeasance and justice
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Autonomy, beneficence, universality and justice
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Autonomy, beneficence, non-malfeasance and justice
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
6. The amount of drug available in the bloodstream is considered the:
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
,- Bioavailability of the drug
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Properties of protein-binding
||\\|//|| ||\\|//|| ||\\|//||
- Liver enzyme activity
||\\|//|| ||\\|//|| ||\\|//||
- First pass mechanism
||\\|//|| ||\\|//|| ||\\|//||
Bioavailability of the drug ||\\|//|| ||\\|//|| ||\\|//||
7. A patient is being treated with psychotropic medications. He wonders which of the
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
following would affect his medications, by acting as an enzyme inducer: ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Smoking
||\\|//||
- coffee with sugar
||\\|//|| ||\\|//|| ||\\|//||
- black coffee
||\\|//|| ||\\|//||
- grapefruit juice
||\\|//|| ||\\|//||
- Smoking
||\\|//||
8. A 22 y/o patient is newly diagnosed with bipolar I disorder. When asked if she will need
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
medications for the rest of her life, the PMHNP said, "Bipolar is a chronic disease which ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
generally requires medication to treat it." Which ethical principle was used?
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- fidelity
||\\|//||
- veracity
||\\|//||
- autonomy
||\\|//||
- maleficence
||\\|//||
- veracity
||\\|//||
9. Poor health outcomes among African Americans and other minorities are attributed to:
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
, - The genetic predisposition for illness found among minorities
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Poor adherence on the part of the African American patient
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Discrimination, cultural barriers, and lack of access to health care
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- The belief among African Americans that prayer is more powerful than drugs
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Discrimination, cultural barriers, and lack of access to health care
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
10. Non-adherence is especially common in drugs that treat psychiatric conditions, such as
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
depression. One way to reduce the likelihood of non-adherence to th drugs is to prescribe a ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
drug that:
||\\|//|| ||\\|//||
- Must be taken three times a day
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Requires several dosage titrations so that missed doses can be replaced with lower doses
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
to keep costs down ||\\|//|| ||\\|//|| ||\\|//||
- Has a tolerability profile with fewer of the adverse effects that are considered "irritating,"
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
such as nausea and dizziness ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Has a short half-life so that missing one dose has limited effect
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
- Has a tolerability profile with fewer of the adverse effects that are considered "irritating,"
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
such as nausea and dizziness ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
11. All Florida prescribers are required to register for:
||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//|| ||\\|//||
DEA databank ||\\|//||
EFORCSE
F-FORCE
K-FORCE
EFORCSE
